Homegrown drugmaker Alkem Laboratories Ltd has struck separate deals to acquire two smaller peers for a cumulative Rs 287 crore ($32.8 million) in cash, as it looks to expand its product portfolio and ...

Alkem Laboratories has announced two acquisitions – in the dermatology and medical device segments – to strengthen its position in the domestic market. The company has signed a binding term ...

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.

For Q3FY25, Alkem reported a 6% year-on-year increase in net profit to ₹641 crore, though profit declined 9% sequentially. (Image: Pixabay) Alkem Laboratories Ltd has announced the acquisition ...

Pharma stock Alkem Labs announced its results for the quarter ended December 2024 (Q3FY24) on Friday, February 7. The company’s consolidated net profit rose 6 percent year-on-year (YoY ...

Alkem Laboratories Ltd share price was up by 1.14% from the previous closing price of ₹5,048.45. Who are peers of Alkem Laboratories Ltd? The peers of Alkem Laboratories Ltd are Sun ...

Alkem's promoters, with a 56.38% stake worth about Rs 42,280 crore, have hired Nomura as the banker for the stake sale. Reports suggested that Alkem's promoter was aiming to sell 8.5 lakh shares ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Alkem Labs has acquired Adroit Biomed and Bombay Ortho Industries for around Rs 290 crore to boost its domestic market positioning. These strategic acquisitions will enable Alkem to diversify its ...